{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:05:40Z","timestamp":1769522740378,"version":"3.49.0"},"publisher-location":"New York, NY","reference-count":22,"publisher":"Springer New York","isbn-type":[{"value":"9781493970568","type":"print"},{"value":"9781493970575","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-7057-5_2","type":"book-chapter","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T12:48:10Z","timestamp":1499086090000},"page":"23-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A Protocol for the Preparation of Cryoprecipitate and Cryo-depleted Plasma for Proteomic Studies"],"prefix":"10.1007","author":[{"given":"Rosemary L.","family":"Sparrow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Greening","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,4]]},"reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/203312a0","volume":"203","author":"JG Pool","year":"1964","unstructured":"Pool JG, Gershgold EJ, Pappenhagen AR (1964) High-potency Antihaemophilic factor concentrate prepared from Cryoglobulin precipitate. Nature 203:312","journal-title":"Nature"},{"issue":"84","key":"2_CR2","first-page":"70","volume":"17","author":"JG Pool","year":"1965","unstructured":"Pool JG (1965) Preparation and testing of antihemophilic globulin (factor 8) sources for transfusion therapy in hemophilia. Description of a new sterile concentrate process for blood banks. Scand J Clin Lab Invest 17(84):70\u201377","journal-title":"Scand J Clin Lab Invest"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.tmrv.2009.03.001","volume":"23","author":"JL Callum","year":"2009","unstructured":"Callum JL, Karkouti K, Lin Y (2009) Cryoprecipitate: the current state of knowledge. Transfus Med Rev 23:177\u2013188","journal-title":"Transfus Med Rev"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.beha.2005.01.026","volume":"19","author":"WN Erber","year":"2006","unstructured":"Erber WN, Perry DJ (2006) Plasma and plasma products in the treatment of massive haemorrhage. Best Pract Res Clin Haematol 19:97\u2013112","journal-title":"Best Pract Res Clin Haematol"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0140-6736(78)91324-7","volume":"2","author":"EC Mason","year":"1978","unstructured":"Mason EC (1978) Thaw-siphon technique for production of cryoprecipitate concentrate of factor VIII. Lancet 2:15\u201317","journal-title":"Lancet"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1046\/j.1537-2995.1979.19179160274.x","volume":"19","author":"GA Rock","year":"1979","unstructured":"Rock GA, Tittley P (1979) The effects of temperature variations on cryoprecipitate. Transfusion 19:86\u201389","journal-title":"Transfusion"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1423-0410.1979.tb04437.x","volume":"36","author":"GA Rock","year":"1979","unstructured":"Rock GA, Cruickshank WH, Tackaberry ES, Palmer DS (1979) Improved yields of factor VIII from heparinized plasma. Vox Sang 36:294\u2013300","journal-title":"Vox Sang"},{"key":"2_CR8","first-page":"60a","volume":"98","author":"E Shanbrom","year":"2001","unstructured":"Shanbrom E, Owens WJ (2001) A novel method to enhance the formation of cryoprecipitate from fresh plasma. Blood 98:60a","journal-title":"Blood"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1365-2257.2006.00785.x","volume":"28","author":"H Yousef","year":"2006","unstructured":"Yousef H, Neurath D, Freedman M, Rock G (2006) Cryoprecipitate production: the use of additives to enhance the yield. Clin Lab Haematol 28:237\u2013240","journal-title":"Clin Lab Haematol"},{"key":"2_CR10","volume-title":"Technical manual","author":"MK Fung","year":"2014","unstructured":"Fung MK, Grossman BJ, Hillyer CD, Westhoff CM, American Association Of Blood Banks (2014) Technical manual, 18th edn. American Association of Blood Banks, Bethesda, MD","edition":"18"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1423-0410.1980.tb02358.x","volume":"38","author":"RT Wensley","year":"1980","unstructured":"Wensley RT, Snape TJ (1980) Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield. Vox Sang 38:222\u2013228","journal-title":"Vox Sang"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000119543","volume":"26","author":"E Meilin","year":"2008","unstructured":"Meilin E, Sela S, Kristal B (2008) Heparin cryoprecipitation reduces plasma levels of non-traditional risk factors for atherosclerosis in vitro. Blood Purif 26:238\u2013248","journal-title":"Blood Purif"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1097\/ALN.0b013e3181672668","volume":"108","author":"NM Elkassabany","year":"2008","unstructured":"Elkassabany NM, Meny GM, Doria RR, Marcucci C (2008) Green plasma-revisited. Anesthesiology 108:764\u2013765","journal-title":"Anesthesiology"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1258\/acb.2012.012032","volume":"49","author":"V Brunel","year":"2012","unstructured":"Brunel V, Larson T, Peschanski N, Cauliez B (2012) Evaluation of haemolysis in emergency department samples requesting high sensitivity troponin T measurement. Ann Clin Biochem 49:509\u2013510","journal-title":"Ann Clin Biochem"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/j.1537-2995.2011.03079.x","volume":"51","author":"K Peffer","year":"2011","unstructured":"Peffer K, de Kort WL, Slot E, Doggen CJ (2011) Turbid plasma donations in whole blood donors: fat chance? Transfusion 51:1179\u20131187","journal-title":"Transfusion"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/trf.13571","volume":"56","author":"L Green","year":"2016","unstructured":"Green L, Backholer L, Wiltshire M, Platton S et al (2016) The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours. Transfusion 56:1356\u20131361","journal-title":"Transfusion"},{"key":"2_CR17","first-page":"28","volume-title":"Standards of blood banks and transfusion services","author":"J Levitt","year":"2014","unstructured":"Levitt J (2014) Standards of blood banks and transfusion services, 23rd edn. American Association of Blood Banks, Bethesda, MD, p 28","edition":"23"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tmrv.2008.12.004","volume":"23","author":"C Prowse","year":"2009","unstructured":"Prowse C (2009) Properties of pathogen-inactivated plasma components. Transfus Med Rev 23:124\u2013133","journal-title":"Transfus Med Rev"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1111\/trf.12460","volume":"54","author":"J Coene","year":"2014","unstructured":"Coene J, Devreese K, Sabot B, Feys HB et al (2014) Paired analysis of plasma proteins and coagulant capacity after treatment with three methods of pathogen reduction. Transfusion 54:1321\u20131331","journal-title":"Transfusion"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1111\/trf.12602","volume":"54","author":"KS Chan","year":"2014","unstructured":"Chan KS, Sparrow RL (2014) Microparticle profile and procoagulant activity of fresh-frozen plasma is affected by whole blood leukoreduction rather than 24-hour room temperature hold. Transfusion 54:1935\u20131944","journal-title":"Transfusion"},{"key":"2_CR21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood.V68.1.307.307","volume":"68","author":"JN George","year":"1986","unstructured":"George JN, Pickett EB, Heinz R (1986) Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood 68:307\u2013309","journal-title":"Blood"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00281-010-0239-3","volume":"33","author":"O Morel","year":"2011","unstructured":"Morel O, Morel N, Jesel L, Freyssinet JM et al (2011) Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis. Semin Immunopathol 33:469\u2013486","journal-title":"Semin Immunopathol"}],"container-title":["Methods in Molecular Biology","Serum\/Plasma Proteomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7057-5_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T12:03:31Z","timestamp":1602417811000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7057-5_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9781493970568","9781493970575"],"references-count":22,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7057-5_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"4 July 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}